Current projects

We encourage prospective D/P's (donor/participants) to become involved in current and future studies. If a study listed does not apply to your particular situation we still invite you to register so that we may include you in our database and contact you for future studies.

We are looking for D/P's in the following categories:

ID # Required D/P's Enrolled D/P's Remaining D/P's Inclusion Criteria
340639 1000 1 999 Protocol: COL-RESP-528_Testeng services for samples collected at external facilities
340638 1000 0 1000 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections - Miami
340210 3 3 0 Pre-Selected HCV Genotype Samples from Inventory
339974 3 6 -3 Pre-Selected HCV Genotype 4 Samples from Inventory
339914 3 5 -2 Pre-Selected Anti-HBc Positive Serum Samples from Inventory
339838 100 1 99 Urine samples from CT/GC Positive Donors
339834 10 1 9 Self-collected vaginal swab samples from CT/GC Positive Donors
339522 20 25 -5 Pre-Selected Serum Samples from Inventory
339371 3 3 0 Pre-Selected HSV-2 Negative Serum samples from Inventory
339357 7 7 0 Pre-Selected HSV-2 Positive Serum samples from Inventory
339238 50 56 -6 Pre-selected HxV Negative Serum from Young Adults (non-smoking) from Inventory
339042 159 2 157 HxV-VL Testing in Abbott m2000
338900 30 15 15 High Volume K3EDTA Plasma Collection From Healthy Donors TZC0087368/SRF_0003346
338862 1 3 -2 Pre-selected HCV Positive Samples with High Viral Load
338317 32 29 3 Pre-Selected Trep and/or RPR Positive Samples from Inventory
338316 5 5 0 Pre-Selected Trep and RPR Negative Samples from Inventory
337877 5 2 3 Pre-Selected HIV-2 Positive Samples from Inventory
337876 8 5 3 Pre-Selected RPR Positive Samples from Inventory
337875 2 2 0 Pre-Selected HBsAg positive samples from Inventory.
337519 1 1 0 Pre-Selected Flu A Positive Dry Swabs from Inventory
337518 2 3 -1 Pre-Selected Flu B Positive Dry Swabs from Inventory
337517 14 14 0 Pre-Selected COVID Positive Dry Swabs from Inventory
337401 4 3 1 Pre-Selected Anti-HBc Positive Samples from Inventory
337185 47 45 2 Pre-Selected HIV-1 Positive Samples with CD4 count within 200-499 from Inventory
336950 250 54 196 Pre-Selected HIV-2 Viral Load sample for screening.
336858 250 250 0 Pre-Selected HIV-2 High Risk Samples Collected in West Africa from Inventory
336856 60 55 5 Collection protocol for Panel construction (Custom HxV panels, Q_17332)
336799 100 102 -2 Self Collected Vaginal Swabs from Symptomatic Donors
335726 100 5 95 SARS-CoV-2, Flu A, Flu B, and RSV Positive Nasal, Oropharyngeal, Nasopharyngeal and Blood Collection Protocol
335646 2 2 0 Pre-Selected HBV Viral Load Serum Samples from Inventory
335640 110 293 -183 Pre-Selected HCV Viral Load Serum Samples from Inventory
335624 110 6 104 Pre-Selected HIV-2 Viral Load Plasma samples from Inventory
335606 110 62 48 Pre-Selected HIV-1 Viral Load Serum samples from Inventory
335599 110 76 34 Pre-Selected HIV-1 Hight Viral Load Plasma samples from Inventory
334050 300 98 202 Female Vaginal Sample Collection Protocol for CT/GC Symptomatic donors
333600 41 41 0 Pre-Selected UTI Positive Urine samples from Inventory
331596 115 20 95 Prospective collection from Healthy Donors
330660 80 80 0 CT/GC panels to be tested in Abbott and Binx
329522 4338 4402 -64 Disposition of BioRepository Samples -Urine Negative samples from Talents
329373 100 0 100 Prospective Blood Collection Protocol from with elevated ALT levels (>200 IU/L) and Symptomatic of HAV infection.
Symptoms: Jaundice, ALT levels >200 IU/L, Fever, Fatigue, Loss of appetite
Nausea, Vomiting, Abdominal pain, Dark urine, Diarrhea, Clay-colored stool
and Joint pain.
327905 50 6 44 Serum and Plasma samples from Pregnant donors with a high risk of HSV-2 Infection.
326193 20 1 19 Vaginal Swabs from Chlamydia Trachomatis Positive Donors
324122 100 746 -646 Pre-selected Samples for Abbott (Generic JR)
323992 8 0 8 Pre-Selected Covid Negative Plasma Samples from HxV negative donors. De Pruebaaa
321260 50 10 40 Prospective collection from Healthy Donors
321096 22 28 -6 Pre-Selected EBV positive samples (Antibodies)
319565 80 31 49 HIV, HCV, HBV and Syphilis cassette Testing using samples from our Inventory.
317251 100 48 52 Pre-Selected CMV samples with Viral Load
316979 100 100 0 Pre-Selected Treponema pallidum positive samples
316965 100 26 74 HxV-VL Testing in Abbott m2000
312456 1000 200 800 Protocol: COL-RESP-528_Testeng services for samples collected at external facilities
311816 600 1000 -400 Protocol: LIA-STI-497- Cobas CT/NG/MG Nucleic Acid Test for use on the Cobas Liat System: Clinical Performance Evaluation
305552 1000 128 872 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections - Miami
303165 80 0 80 Prospective Rectal Swab Collection
301909 800 1007 -207 Abbott RealTime CT/NG Testing, Cepheid_248C
299865 30 304 -274 Nasal Collection Protocol for Flu A/FluB positive donors
299254 60 95 -35 Cervical and Vaginal Swabs from HPV Positive and Negative Donors
293753 60 19 41 Female Vaginal Sample Collection Protocol for CT/GC positive donors
293648 30 13 17 Prospective Collection for subjects with CoV-2, Flu A, Flu B, RSV
292590 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Nasal Swab, Pharyngeal Swab, Vaginal Swab, Rectal Swab, Lesion Swab, Saliva Sample and/or Blood Samples from a positive or suspected positive D/Ps with Monkeypox
283190 200 113 87 Protocol No. LIA-STI-250 - cobas CT/NG/MG Nucleic acid test for use on the cobas Liat System: Feasibility Performance Evaluation
282613 100 0 100 Rapigen-001 - Clinical Study Protocol - BIOCREDIT COVID-19 Ag Home Test Nasal (Puerto Rico)
282610 10000 0 10000 A Multi Site, Longitudinal, Prospective Sample Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
266931 120 17 103 PAS-19SUST053 Testing HBV VL (Abbott & Hologic)
266866 120 26 94 Protocol: FD-001 - Clinical Evaluation of the Fosun COVID-19 Ag Home Test In Symptomatic and Asymptomatic Subjects
261154 800 1892 -1092 Protocol: LIA-CoV-560 - cobas SARS-CoV-2 and cobas SARS-CoV-2 & Influenza A/B Nucleic acid tests for use on the cobas Liat® System: Clinical Performance Evaluation
251350 100 44 56 SARS-CoV-2 Positive Nasal, Oropharyngeal Dry Swab and Raw Saliva Collection Protocol
242206 5000 27665 -22665 COVID-19 Testing
239188 500 0 500 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
227994 130 5 125 PAS-19SUST054 - HCV
225611 10000 0 10000 A Multi Site, Longitudinal, Prospective Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
224514 600 76 524 Initiative to Screen Potential Study Candidates (SUST)
190737 5000 67 4933 SARS-CoV-2 Survey (PT)
182696 1000 355 645 Protocol: COL-RESP-528 - Collection of Respiratory Swab Samples from Patients with Suspected Respiratory Tract Infections
175121 1000 27 973 CBC Initiative
173768 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain Saliva, Sputum, Nasal, Pharyngeal, Blood and/or Finger Stick Specimens from SARS-CoV-2 positive subjects
152854 10000 0 10000 A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
151681 5000 3 4997 Refer to Processing Instructions @ Attachment Tab
149547 5000 320 4680 Refer to Processing Instructions @ Attachment Tab
TESTS TO SELECT PER LOCATION - REFER TO ATTACHMENT TAB
148791 5000 48 4952 Refer to Processing Instructions @ Attachment Tab
145574 5000 130 4870 Refer to Processing Instructions @ Attachment Tab
144620 5000 61 4939 Refer to Processing Instructions @ Attachment Tab
142755 5000 132 4868 Refer to Processing Instructions @ Attachment Tab
141914 1000 7 993 HIV Initiative
141493 5000 60 4940 HCV Viral Load and Genotype Survey (PT)
141491 5000 24 4976 HBV Viral Load Survey (PT)
141490 5000 60 4940 HIV Viral Load Survey (PT)
140923 5000 125 4875 Refer to Processing Instructions @ Attachment Tab
140922 5000 65 4935 Refer to Processing Instructions @ Attachment Tab
140530 5000 10 4990 Rubella IgG (AAB - PT)
140528 5000 6 4994 ToRCH (AAB - PT)
139409 5000 137 4863 Pregnancy (PT)
137933 5000 0 5000 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon
129688 200 163 37 EBV / EBK Samples from National Center of Urology - Tbilisi, Georgia
129538 1000 309 691 RPR Initiative
128402 1000 73 927 CBC Initiative
124266 5000 143 4857 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cote D'Ivoire
122931 5000 3767 1233 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
122654 5000 171 4829 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Swaziland
120851 140 26 114 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
109382 100 32 68 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV
109381 300 6 294 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
108692 1000 1178 -178 HxV Testing Initiative
102419 1000 503 497 Samples on hold for future shipments to China
98830 10000 0 10000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP, Endocervical Swab, Vaginal Swab, Nasal Swab, Pharyngeal Swab, Rectal Swab, Urethral Swab and/or Urine Samples
98084 1000 577 423 CBC Qualifying Job Request
96278 195 185 10 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
96055 40 2132 -2092 Hologic Panels for HIV and HCV
94841 500 1 499 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV - LGR
80997 5000 428 4572 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV from Cameroon
78138 300 140 160 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HCV
78137 300 414 -114 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV
74261 10000 0 10000 A Recurrent Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from D/Ps that have been Diagnosed or Suspected to have HIV, HBV, HCV, Syphilis, CMV, Toxo and/or Rubella
68258 10000 0 10000 A Multi Site, Longitudinal, Prospective Blood Collection Protocol in order to obtain Samples from Normal Healthy D/Ps
63868 1000 1386 -386 Blinded HIV/HBV/HCV Prospective Blood Collection Protocol from Guinea Bissau
56717 20000 0 20000 A Multi-Site, Multi-Point, Prospective Collection Protocol in order to obtain PAP , Endocervical, Vaginal, Nasal and/or Urine Samples
55075 10000 28 9972 Beta HCG Matched Set Prospective Blood Collection Protocol
54664 200 148 52 Random Cadaveric Samples
27615 15000 633 14367 Prospective Blood Collection Protocol in order to Collect Samples from Donor/Participants (D/Ps) in Low Socio-Economic Regions of the World
26761 10000 482 9518 HIV Positive Time Stability Whole Blood Collection Protocol
10694 3000 2234 766 HCV Longitudinal Prospective Blood Collection Protocol
10693 3000 369 2631 HBV Multi-Point Prospective Blood Collection Protocol
8568 300 1750 -1450 Positive Plasma Units from Blood Centers Around the World (HIV, HBsAg & HCV)



BCW helps clinicians during their research process through collection sites and D/P availability. Our collection sites have been duly inspected and adhere to our Good Manufacturing Practices thus ensuring reliability during the collection process. In addition to this we provide training seminars as part of our Quality Assurance in order to maintain the level of quality that our customers are accustomed to.

You will be invited to participate in research studies for the advancement of diagnostic technologies. Participation in these studies is voluntary. Our D/P's are informed of what the research projects are about and are given an Informed Consent, which evidences their willingness to participate. In order to protect our D/P's we never divulge your identity to the research facilities thus guaranteeing D/P confidentiality.



Contact us to learn more